studi
test
hypothesi
activ
mitogenactiv
protein
kinas
mapk
physiologicallyrelev
concentr
contribut
enhanc
cytokin
express
stimul
human
natur
killer
nk
cell
canon
trigger
type
cytokin
respons
cytokin
also
synerg
type
cytokin
like
provok
interferongamma
show
picogram
concentr
suffici
promot
robust
secret
human
nk
cell
greatli
exce
respons
either
cytokin
alon
nanogram
dose
potenti
consist
level
tissu
microenviron
synerg
induc
secret
addit
cytokin
includ
tumor
necrosi
factor
tnf
granulocytemacrophag
colonystimul
factor
gmcsf
activ
mapk
pathway
human
nk
cell
crucial
enhanc
releas
tnf
respons
mechanist
mapk
signal
enhanc
stabil
ifng
transcript
trigger
cleavag
tnf
cell
surfac
data
support
hypothesi
suggest
alter
sensit
nk
cell
presenc
may
import
consequ
diseas
associ
mix
cytokin
milieu
like
asthma
chronic
obstruct
pulmonari
diseas
innat
lymphoid
cell
mapk
nk
cell
gmcsf
tnf
synergi
asthma
copd
graphic
abstract
authorfund
right
reserv
reus
allow
without
permiss
natur
killer
nk
cell
play
key
role
clearanc
virusinfect
cell
pathogenesi
mani
diseas
type
cytokin
provok
canon
interferongamma
respons
nk
cell
type
cytokin
includ
enhanc
releas
nk
cell
type
cytokin
synergi
also
promot
enhanc
releas
tumor
necrosi
factoralpha
tnf
granulocyt
macrophag
coloni
stimul
factor
gmcsf
thu
type
cytokin
rich
environ
associ
immun
insult
infect
injuri
stimul
cytokin
respons
nk
cell
promot
type
respons
exampl
experiment
model
leishmania
infantum
combin
critic
nkcell
express
central
dogma
cytokin
biolog
hold
type
cytokin
eg
suppress
type
cytokin
respons
type
cytokin
eg
correspondingli
suppress
type
respons
thu
type
cytokin
put
suppress
nkcell
product
yet
prototyp
typic
type
cytokin
alon
combin
trigger
high
level
express
mous
nk
cell
anoth
type
cytokin
enhanc
product
nk
nkt
cell
thu
nk
cell
type
cytokin
rich
environ
may
exhibit
hypersensit
respons
follow
infect
insult
present
studi
confirm
primari
human
nk
cell
treat
combin
ex
vivo
produc
high
level
extend
observ
near
physiolog
picogram
concentr
cytokin
mechanist
implic
mitogenactiv
protein
kinas
mapk
pathway
enhanc
respons
human
nk
cell
uncov
role
enhanc
releas
tnf
stimulatori
condit
data
provid
mechanist
insight
inflammatori
milieu
may
directli
enhanc
proinflammatori
activ
nk
cell
bolster
protein
express
stimul
human
nk
cell
whether
enhanc
occur
level
transcript
unknown
test
isol
nk
cell
blood
healthi
deidentifi
adult
prior
incub
cell
media
contain
combin
cytokin
six
hour
concentr
ngml
induc
increas
ifng
express
compar
unstimul
cell
ngml
insuffici
induc
respons
fig
addit
nk
cell
cultur
either
dose
result
increas
interact
p
twoway
anova
ifng
mrna
express
level
fig
similar
fashion
tnf
transcript
express
increas
interact
twoway
anova
combin
comparison
alon
fig
type
innat
lymphocyt
stimul
express
contrast
alon
combin
measur
effect
express
express
human
nk
cell
fig
next
sought
examin
whether
nearphysiolog
concentr
could
provok
enhanc
express
stimul
nk
cell
isol
nk
cell
secret
respons
dose
low
pgml
fig
contrast
product
cell
bare
detect
stimul
alon
even
dose
high
ngml
fig
howev
pgml
enhanc
protein
express
fig
synergist
interact
contribut
significantli
p
twoway
anova
overal
variat
express
high
concentr
ngml
addit
provok
express
tnf
gmcsf
administ
combin
fig
bulk
variat
express
tnf
twoway
anova
gmcsf
twoway
anova
attribut
synergist
interact
fig
antibodi
blockad
receptor
abrog
enhanc
effect
express
consist
previou
studi
measur
effect
induc
alon
fig
figur
enhanc
cytokin
express
primari
human
nk
cell
enrich
primari
human
nk
cell
stimul
combin
dose
list
ngml
hour
prior
elisa
determin
b
tnf
gmcsf
express
cellfre
supernat
result
one
repres
iter
ten
b
five
similar
experi
use
cell
differ
subject
shown
dot
biolog
replic
column
repres
mean
result
ordinari
oneway
anova
b
assess
group
mean
multipl
comparison
shown
twoway
anova
use
assess
synergist
cytokin
interact
report
result
text
sinc
part
superfamili
includ
potent
costimul
express
nk
cell
sought
examin
receptor
play
role
synergi
observ
contrast
blockad
blockad
effect
abil
enhanc
releas
fig
prevent
synergi
fig
macrophag
stimul
activ
mapk
determin
activ
mapk
human
nk
cell
measur
phosphoryl
mapk
downstream
target
kinas
flow
cytometri
primari
human
nk
cell
cultur
stimul
cytokin
phosphoryl
mapk
activ
transcript
factor
measur
flow
cytometri
stimul
irrespect
presenc
stimul
mapk
phosphoryl
within
minut
cytokin
exposur
fig
level
mapk
remain
elev
least
minut
poststimul
likewis
stimul
induc
phosphoryl
albeit
slower
kinet
fig
contrast
induc
phosphoryl
fig
extent
mapk
fig
fig
well
fig
measur
alter
time
scale
coadministr
cytokin
determin
role
mapk
enhanc
cytokin
specif
mapk
inhibitor
employ
nk
cell
pretreat
nm
minut
prior
stimul
ngml
ngml
hour
none
concentr
inhibitor
use
studi
measur
affect
cell
viabil
data
shown
dose
nm
restor
express
respons
plu
level
seen
alon
fig
concentr
measur
impact
express
absenc
fig
diminish
enhanc
effect
tnf
express
fig
enhanc
product
promot
ifng
transcript
stabil
mediat
mapk
signal
determin
whether
exert
similar
effect
ifng
transcript
stabil
human
nk
cell
incub
alon
combin
hour
conjunct
pretreat
vehicl
control
four
hour
cytokin
administr
cultur
treat
actinomycin
halt
de
novo
transcript
therebi
permit
measur
decay
exist
ifng
transcript
shown
fig
ifng
level
drop
experiment
group
addit
actinomycin
treatment
nk
cell
fig
dark
purpl
result
significantli
greater
halflif
ifng
transcript
minut
versu
minut
p
compar
nk
cell
stimul
alon
fig
solid
black
line
dark
gray
bar
addit
acceler
decay
infg
transcript
fig
left
plot
dash
line
larg
abrog
enhanc
effect
fig
right
plot
light
purpl
bar
rel
alon
fig
right
plot
light
grey
bar
term
halflif
ifng
transcript
minut
versu
minut
thu
act
enhanc
ifng
transcript
stabil
via
mapk
previou
studi
show
mapkmapk
downstream
mapk
mediat
inflammatori
respons
addit
specif
inhibitor
iv
nkcell
cultur
diminish
enhanc
effect
product
fig
contrast
dose
iv
test
complet
abrog
enhanc
express
thu
contribut
enhanc
effect
fulli
account
effect
mediat
mapk
tnf
shed
cell
membran
via
activ
addit
induc
increas
tnf
mrna
express
fig
hypothes
enhanc
tnf
secret
nk
cell
fig
via
elev
cleavag
cellsurfac
tnf
addit
inhibitor
nkcell
cultur
result
reduct
secret
tnf
pgml
elisa
respons
stimul
fig
contrast
complet
ablat
enhanc
effect
tnf
secret
thu
enhanc
tnf
secret
respons
least
partial
depend
may
function
downstream
mapk
depend
mapk
induc
chang
tnf
mrna
express
secret
tnf
secret
increas
respons
combin
cellassoci
tnf
reduc
level
near
induc
alon
fig
flow
cytometri
measur
made
absenc
brefeldina
secret
inhibitor
thu
reflect
tnf
natur
retain
cell
importantli
reduc
tnf
secret
tapiitr
stimul
cell
fig
associ
increas
cellassoci
tnf
level
observ
alon
fig
thu
activ
contribut
tnf
secret
expens
cellassoci
tnf
like
via
cleavag
tnf
cell
surfac
augment
previou
observ
mous
human
nk
cell
show
nearphysiolog
eg
pm
concentr
type
cytokin
trigger
hypersensit
primari
human
nk
cell
type
cytokin
addit
superphysiolog
concentr
synergist
induc
releas
tnf
gmcsf
suggest
high
concentr
cytokin
tissu
microenviron
may
even
stronger
effect
nkcell
function
potenti
tnf
secret
depend
mapk
lesser
extent
downstream
kinas
moreov
enhanc
tnf
secret
partial
attribut
result
highlight
possibl
exagger
cytokin
secret
human
nk
cell
physiolog
set
character
dual
exposur
type
type
cytokin
type
cytokin
enhanc
express
ifng
human
nk
cell
part
via
mapk
stabil
ifng
transcript
data
suggest
type
cytokin
similarli
enhanc
express
human
nk
cell
moreov
amplif
depend
mapk
activ
associ
increas
stabil
ifng
mrna
mapk
regul
inflammatori
respons
via
phosphoryl
downstream
mediat
includ
yet
inhibitor
partial
inhibitori
effect
contrast
abrog
synergist
interact
follow
mapk
inhibit
find
impli
mapkstimul
mediat
includ
may
also
crucial
enhanc
effect
fact
rapidli
induc
phosphoryl
mapk
human
nk
cell
note
mapkinduc
activ
initi
activ
protein
complexmedi
transcript
inflammatori
cytokin
includ
coupl
lack
appar
effect
phosphoryl
result
highlight
possibl
enhanc
via
enhanc
promot
transcript
addit
mapkdriven
intracellular
signal
lead
transcript
factor
activ
mapk
also
directli
phosphoryl
membran
protein
like
activ
mapk
promot
shed
tnf
data
consist
possibl
reveal
mapkdepend
enhanc
tnf
express
coupl
releas
cellassoci
tnf
collect
data
suggest
mapk
govern
sever
molecular
pathway
regul
inflammatori
cytokin
releas
human
nk
cell
abil
type
cytokin
mediat
releas
limit
past
studi
demonstr
enhanc
product
murin
stimul
nk
cell
also
observ
enhanc
product
human
nk
cell
snw
unpublish
observ
wherea
predomin
signal
via
activ
cytokin
appear
capabl
trigger
mapk
pathway
fact
synergi
mous
nk
cell
partial
depend
mapk
whether
distinct
type
cytokin
enhanc
product
via
similar
distinct
mechan
remain
determin
patholog
asthma
copd
play
central
role
diseas
patholog
patholog
shown
exacerb
respiratori
viral
infect
mediat
releas
type
cytokin
thu
specul
nk
cell
deriv
blood
tissu
patient
exhibit
elev
level
would
sensit
ex
vivo
stimul
exampl
cigarett
smoke
induc
epitheli
damag
result
increas
express
provok
hypersensit
product
mous
nk
cell
respons
initi
data
suggest
nk
cell
smoker
exhibit
greater
sensit
term
express
nk
cell
deriv
healthi
nonsmok
mb
snw
unpublish
observ
specul
elev
level
smoker
asthmat
patient
provok
hypersensit
type
inflammatori
cue
trigger
viru
infect
thu
smoker
expos
viru
infect
like
produc
high
potenti
pathogen
express
find
provid
new
insight
potenti
function
hypersensit
nk
cell
type
cytokin
rich
inflammatori
milieu
asthma
copd
well
smoker
human
cell
deidentifi
blood
sampl
obtain
healthi
donor
defin
hoxworth
blood
center
guidelin
http
hoxworthorgdonorseligibilityhtml
approv
cincinnati
children
hospit
medic
center
institut
review
board
peripher
blood
mononuclear
pbmc
cell
isol
ficollhystopaqu
ge
marlborough
gradient
nk
cell
enrich
neg
select
use
nkcell
isol
kit
immun
magnet
bead
per
manufactur
protocol
miltentyi
biotec
san
diego
ca
enrich
cell
neg
nk
cell
determin
flow
cytometri
vitro
cultur
nk
cell
enrich
nk
cell
cultur
scgm
media
freiburg
germani
supplement
uml
peprotech
rocki
hill
nj
human
serum
sigma
st
loui
mo
heatinactiv
fetal
bovin
serum
uml
penicillin
uml
streptomycin
nonessenti
amino
acid
sodium
pyruv
lglutamin
mm
hepe
experi
nk
cell
either
use
directli
blood
isol
day
ex
vivo
cultur
scenario
produc
similar
result
antibodi
follow
antibodi
use
describ
studi
brilliant
violet
bv
alexafluor
af
purchas
biolegend
san
diego
ca
brilliant
ultra
violet
buv
purchas
becton
dickinson
san
diego
ca
invitrogen
carlsbad
ca
mous
antihuman
unconjug
antihuman
r
minneapoli
mn
antibodi
use
dose
titrat
lab
cytokin
stimul
enrich
nk
cell
unless
mention
otherwis
per
well
triplic
per
condit
cultur
overnight
presenc
uml
variou
concentr
rocki
hill
nj
ad
cultur
hour
cellfre
supernat
collect
analyz
elisa
level
human
tnf
gmcsf
invitrogen
waltham
inhibit
mitogenactiv
protein
kinas
mapk
activ
nm
measur
select
mapk
inhibitor
pamapimod
selleckchem
houston
tx
ad
minut
prior
cytokin
stimul
inhibit
protein
kinaseactiv
protein
kinas
perform
iv
cayman
chemic
ann
arbor
mi
inhibit
disintegrin
perform
ad
merck
millipor
burlington
iv
ad
minut
cytokin
stimul
test
concentr
none
test
inhibitor
affect
cell
viabil
data
shown
mrna
stabil
assay
primari
human
nk
cell
cultur
cell
per
well
cell
treat
media
dmso
ngml
without
ngml
actinomycin
sigma
ad
cell
cultur
hour
cytokin
treatment
rna
isol
addit
actinomycin
hour
addit
actinomycin
rna
extract
nk
cell
rneasi
kit
qiagen
hilden
germani
accord
manufactur
instruct
detect
ifng
tnf
mrna
express
perform
use
probe
appli
biosystem
foster
citi
ca
accord
manufactur
instruct
statist
analysi
perform
statist
analys
use
graphpad
prism
use
twoway
anova
identifi
contribut
multipl
variabl
experiment
measur
use
oneway
anova
perform
multipl
comparison
experiment
condit
specif
statist
analysi
test
use
indic
figur
legend
deo
conceptu
investig
data
curat
writingorigin
draft
aa
pca
dk
investig
data
curat
writingedit
lck
data
curat
writingedit
mb
data
curat
writingedit
snw
conceptu
data
curat
writingorigin
draft
studi
supervis
